PEA3 transcription factors are downstream effectors of Met signaling involved in migration and invasiveness of Met-addicted tumor cells

Plasticity versus specificity in RTK signalling modalities for distinct biological outcomes in motor neurons

(2014) Nathalie Caruso et al.   BMC BIOLOGY

PAX3 and ETS1 synergistically activate MET expression in melanoma cells

(2014) J D Kubic et al.   ONCOGENE

Dynamic Reprogramming of Signaling Upon Met Inhibition Reveals a Mechanism of Drug Resistance in Gastric Cancer

(2014) A. Z. Lai et al.   Science Signaling

Pea3 expression promotes the invasive and metastatic potential of colorectal carcinoma

(2014) Aruz Mesci   WORLD JOURNAL OF GASTROENTEROLOGY

Loss of a Negative Feedback Loop Involving Pea3 and Cyclin D2 Is Required for Pea3-Induced Migration in Transformed Mammary Epithelial Cells

(2013) F. Ladam et al.   MOLECULAR CANCER RESEARCH

Receptor Tyrosine Kinases Fall into Distinct Classes Based on Their Inferred Signaling Networks

(2013) J. P. Wagner et al.   Science Signaling

Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer

(2013) Alberto Bardelli et al.   Cancer Discovery

MET in gastric carcinomas: comparison between protein expression and gene copy number and impact on clinical outcome

(2012) H E Lee et al.   BRITISH JOURNAL OF CANCER

Met acts through Abl to regulate p53 transcriptional outcomes and cell survival in the developing liver

(2012) Alessandro Furlan et al.   JOURNAL OF HEPATOLOGY

Transcriptional regulatory networks in human lung adenocarcinoma

(2012) XIANGRUI MENG et al.   Molecular Medicine Reports

Elf5 inhibits the epithelial–mesenchymal transition in mammary gland development and breast cancer metastasis by transcriptionally repressing Snail2

(2012) Rumela Chakrabarti et al.   NATURE CELL BIOLOGY

ETS variant 1 regulates matrix metalloproteinase-7 transcription in LNCaP prostate cancer cells

(2012) SOOK SHIN et al.   ONCOLOGY REPORTS

Overexpression of ETV4 is oncogenic in prostate cells through promotion of both cell proliferation and epithelial to mesenchymal transition

(2012) A Pellecchia et al.   Oncogenesis

The Role of Pea3 Group Transcription Factors in Esophageal Squamous Cell Carcinoma

(2011) Hiu-Fung Yuen et al.   AMERICAN JOURNAL OF PATHOLOGY

PEA3/ETV4-related transcription factors coupled with active ERK signalling are associated with poor prognosis in gastric adenocarcinoma

(2011) R Keld et al.   BRITISH JOURNAL OF CANCER

c-MET/Phospho-MET Protein Expression and MET Gene Copy Number in Non-small Cell Lung Carcinomas

(2011) Koji Tsuta et al.   Journal of Thoracic Oncology

Wild-type p53 controls cell motility and invasion by dual regulation of MET expression

(2011) C.-I. Hwang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Over-Expression of Ephb4 Is Associated with Carcinogenesis of Gastric Cancer

(2010) M. Li et al.   DIGESTIVE DISEASES AND SCIENCES

Genome-wide analysis of ETS-family DNA-binding in vitro and in vivo

(2010) Gong-Hong Wei et al.   EMBO JOURNAL

The E3 ubiquitin ligase complex component COP1 regulates PEA3 group member stability and transcriptional activity

(2010) J-L Baert et al.   ONCOGENE

The Steroid Receptor Coactivator-1 Regulates Twist Expression and Promotes Breast Cancer Metastasis

(2009) L. Qin et al.   CANCER RESEARCH

Increased PEA3/E1AF and decreased Net/Elk-3, both ETS proteins, characterize human NSCLC progression and regulate caveolin-1 transcription in Calu-1 and NCI-H23 NSCLC cell lines

(2009) Karin A. Sloan et al.   CARCINOGENESIS

PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcription

(2009) Rajani Kanteti et al.   LABORATORY INVESTIGATION

Down-Regulation of the Met Receptor Tyrosine Kinase by Presenilin-dependent Regulated Intramembrane Proteolysis

(2009) Bénédicte Foveau et al.   MOLECULAR BIOLOGY OF THE CELL

Etv4 and Etv5 are required downstream of GDNF and Ret for kidney branching morphogenesis

(2009) Benson C Lu et al.   NATURE GENETICS

Only a Subset of Met-Activated Pathways Are Required to Sustain Oncogene Addiction

(2009) A. Bertotti et al.   Science Signaling

Receptor trafficking controls weak signal delivery: a strategy used by c-Met for STAT3 nuclear accumulation

(2008) Stéphanie Kermorgant et al.   JOURNAL OF CELL BIOLOGY

Reduced tumorigenesis in mouse mammary cancer cells following inhibition of Pea3- or Erm-dependent transcription

(2008) V. Firlej et al.   JOURNAL OF CELL SCIENCE

The AIB1 Oncogene Promotes Breast Cancer Metastasis by Activation of PEA3-Mediated Matrix Metalloproteinase 2 (MMP2) and MMP9 Expression

(2008) L. Qin et al.   MOLECULAR AND CELLULAR BIOLOGY

Drug development of MET inhibitors: targeting oncogene addiction and expedience

(2008) Paolo M. Comoglio et al.   NATURE REVIEWS DRUG DISCOVERY